The number of multidrug-resistant tuberculosis (MDR-TB) cases started on treatment in the UK is forecasted to decrease steadily from 42 cases in 2024 to 37 cases by 2028. Comparing this with the actual data from 2023, when there were 45 cases, the projected figures indicate a significant downward trajectory. The year-on-year variation suggests a gradual decrease between 2024 and 2028, translating to an approximate CAGR that reflects this declining trend.

Future trends to watch for include:

Advancements in medical treatment options and protocols for MDR-TB.
Impact of public health initiatives aimed at controlling the spread of tuberculosis.
Potential socio-economic factors that may influence tuberculosis incidence and treatment access in the UK.